Latest Market Research Reports

  The U.S. home infusion therapy market is gaining momentum as patients and healthcare providers increasingly favor treatment at home for conditions that require prolonged infusion therapy. The rising elderly population, growing prevalence of cancer, diabetes, chronic pain, gastrointestinal disorders, cardiovascular diseases, and chronic respiratory diseases are supporting market expansion. Home infusion therapy provides patients with greater convenience and can reduce the need for hospital stays, while also supporting cost-effective care and lowering exposure to hospital-acquired infections. Increasing preference for home-based treatment, improvements in infusion devices, and expanding reimbursement for outpatient and home-based therapies are further strengthening market growth. Market Size and Growth Forecasts The U.S. home infusion therapy market was valued at USD 20.42 billion in 2024 and is estimated to reach USD 21.95 billion in 2025. The market is projected to reach USD 39.9...

U.S. Home Infusion Therapy Industry Overview The  U.S. home infusion therapy market  size is expected to reach USD 31.7 billion by 2030, registering a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The growing geriatric population and increasing prevalence of cancer, Crohn's disease, multiple sclerosis, nutritional and immune deficiencies, infections, dehydration, and nausea & vomiting are majorly driving the growth of the market. Factors such as the increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.   Growing cases of Hospital Acquired Infections (HAI) are also driving the growth of the market for home infusion therapy in the U.S. According to the U.S. Centers for Disease Control and Prevention (CDC), annually, approximately 1.7 million admitted patients are affected by Healthcare Acquired infections (HCAI) and around 98, ...